Unveiling Patient Experiences in Testicular Cancer Clinical Trials
- Conditions
- Testicular Cancer
- Registration Number
- NCT05928377
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical research participation has historically been heavily biased toward specific demographics.
Several people will be invited to enroll in this study so that it may collect a variety of data about testicular cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.
People with testicular cancer who are invited to take part in medical research will benefit from the analysis of the data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Male
- Target Recruitment
- 500
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Diagnosis of testicular cancer
- No prior treatment for testicular cancer
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Enrolled in another research study
- Inability to provide written informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of testicular cancer patients who decide to enroll in a clinical trial 3 months Rate of testicular cancer patients who remain in a clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States